Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Connie R Jimenez
Affiliation
ORCID
Career Start Year
1992
Papers
218
H Index
51
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36916528
Advancing wide implementation of precision oncology: A liquid nitrogen-free snap freezer preserves molecular profiles of biological samples.
2023
37940875
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics.
2023
37665466
Phosphoproteomics After Guanidinium Thiocyanate Extraction of Tissue Biopsies.
2023
37665463
A Robust and Clinically Applicable Sample Preparation Protocol for Urinary Extracellular Vesicle Isolation Suitable for Mass Spectrometry-Based Proteomics.
2023
37585503
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer.
Sci Transl Med
2023
37477020
EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy.
2023
36906835
A transformer architecture for retention time prediction in liquid chromatography mass spectrometry-based proteomics.
2023
37280612
Atrial epicardial adipose tissue abundantly secretes myeloperoxidase and activates atrial fibroblasts in patients with atrial fibrillation.
2023
37209095
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors.
Cell Rep
2023
37023079
C1q is increased in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: A multi-cohort proteomics and immuno-assay validation study.
2023
37269289
Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma.
2023
36639418
Genome-wide siRNA screens identify RBBP9 function as a potential target in Fanconi anaemia-deficient head-and-neck squamous cell carcinoma.
Commun Biol
2023
37454217
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum.
2023
37521047
DPHL v.2: An updated and comprehensive DIA pan-human assay library for quantifying more than 14,000 proteins.
Patterns (N Y)
2023
35081007
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension.
American Journal of Respiratory and Critical Care Medicine
2022
36369736
Integration of stool microbiota, proteome and amino acid profiles to discriminate patients with adenomas and colorectal cancer.
Gut Microbes
2022
36156810
Inferring kinase activity from phosphoproteomic data: Tool comparison and recent applications.
Mass Spectrometry Reviews
2022
35863698
Phosphoproteomic Analysis of FLCN Inactivation Highlights Differential Kinase Pathways and Regulatory TFEB Phosphoserines.
Molecular and Cellular Proteomics
2022
35984965
Donor natural killer cells trigger production of β-2-microglobulin to enhance post-bone marrow transplant immunity.
Blood
2022
35606362
Extracellular vimentin mimics VEGF and is a target for anti-angiogenic immunotherapy.
Nature Communications
2022
36409073
The ESX-1 Substrate PPE68 Has a Key Function in ESX-1-Mediated Secretion in Mycobacterium marinum.
mBio
2022
36255265
Fusicoccin-A Targets Cancerous Inhibitor of Protein Phosphatase 2A by Stabilizing a C-Terminal Interaction with 14-3-3.
ACS Chemical Biology
2022
36050473
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.
Nature
2022
35217681
Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies.
Nature Communications
2022
35165100
Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma.
Clinical Cancer Research
2022
35130834
Secreted protein markers in oral squamous cell carcinoma (OSCC).
Clin Proteomics
2022
34361002
Effects of Cancer Presence and Therapy on the Platelet Proteome.
International Journal of Molecular Sciences
2021
33968084
Quantitative Phosphoproteomic Analysis Reveals Dendritic Cell- Specific STAT Signaling After α2-3-Linked Sialic Acid Ligand Binding.
Frontiers in Immunology
2021
33750427
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma.
J Exp Clin Cancer Res
2021
33587312
Lipopolysaccharide-regulated secretion of soluble and vesicle-based proteins from a panel of colorectal cancer cell lines.
Proteomics Clin Appl
2021
33536523
Neutrophil degranulation interconnects over-represented biological processes in atrial fibrillation.
Scientific Reports
2021
34280333
Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening : A Diagnostic Test Accuracy Study.
Ann Intern Med
2021
34272386
Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies.
Nature Communications
2021
33890711
Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2.
EMBO Rep
2021
33732734
Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy.
Front Cardiovasc Med
2021
33459596
Loss of FLCN-FNIP1/2 induces a non-canonical interferon response in human renal tubular epithelial cells.
eLife
2021
33561558
The influence of delay in mononuclear cell isolation on acute myeloid leukemia phosphorylation profiles.
Journal of Proteomics
2021
34035881
Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles.
J Extracell Vesicles
2021
33602116
Time dependent effect of cold ischemia on the phosphoproteome and protein kinase activity in fresh-frozen colorectal cancer tissue obtained from patients.
Clinical Proteomics
2021
34136754
Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors.
HemaSphere
2021
33819647
Feasibility of Phosphoproteomics on Leftover Samples After RNA Extraction With Guanidinium Thiocyanate.
Mol Cell Proteomics
2021
34341426
Longitudinal stability of urinary extracellular vesicle protein patterns within and between individuals.
Scientific Reports
2021
33307249
Feasibility of phosphoproteomics to uncover oncogenic signalling in secreted extracellular vesicles using glioblastoma-EGFRVIII cells as a model.
Journal of Proteomics
2021
32875713
Computational Analysis of Phosphoproteomics Data in Multi-Omics Cancer Studies.
Proteomics
2021
33341450
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer.
Eur J Cancer
2021
33430602
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy.
Circ Heart Fail
2021
34675268
Simple urine storage protocol for extracellular vesicle proteomics compatible with at-home self-sampling.
Sci Rep
2021
34717701
High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer.
Journal of Experimental and Clinical Cancer Research
2021
31411736
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression.
Int J Cancer
2020
32024067
Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome.
Cancers (Basel)
2020
1 - 50 of 218
Column Actions
Search
Recommended Authors
Collaborators
Remond J A Fijneman
The Netherlands Cancer Institute
Co-authored papers
20
Gerrit A Meijer
The Netherlands Cancer Institute
Co-authored papers
17
Meike de Wit
The Netherlands Cancer Institute
Co-authored papers
17
Alma L Burlingame
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
9
Johannes C van der Mijn
New York Presbyterian Hospital
Co-authored papers
8
Jos Jonkers
Oncode Institute, Netherlands Cancer Institute
Co-authored papers
6
Hanneke W M van Laarhoven
Cancer Center Amsterdam
Co-authored papers
6
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers
5
Lan Huang
University of California Irvine
Co-authored papers
5
Thomas Wurdinger
Co-authored papers
5
Guido Jenster
Erasmus University Medical Center
Co-authored papers
4
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Co-authored papers
4
Malgorzata A Komor
Netherlands Cancer Institute
Co-authored papers
4
Jan H M Schellens
Department of Pharmaceutical Sciences, Utrecht University
Co-authored papers
3
Cristobal G Dos Remedios
Victor Chang Cardiac Research Institute
Co-authored papers
3
Livio Trusolino
Candiolo Cancer Institute - FPO IRCCS
Co-authored papers
3
Giuseppe Giaccone
Meyer Cancer Center
Co-authored papers
3
Andrea Bertotti
Candiolo Cancer Institute - FPO IRCCS
Co-authored papers
3
Hans Clevers
Princess Maxima Center for Pediatric Oncology
Co-authored papers
2
Mark A van de Wiel
Amsterdam University Medical Centers (Amsterdam UMC)
Co-authored papers
2
Mark de Jong
Swammerdam Institute for Life Sciences, University of Amsterdam
Co-authored papers
2
Fredrik Pont??n
Uppsala University
Co-authored papers
2
Edwin Cuppen
Hartwig Medical Foundation
Co-authored papers
2
Tiannan Guo
Westlake University
Co-authored papers
2
Youri Hoogstrate
Erasmus MC Cancer Institute
Co-authored papers
2
Engelbert Knosp
Medical University of Vienna
Co-authored papers
1
Paul J van Diest
University Medical Center Utrecht
Co-authored papers
1
Yu-Ju Chen
Institute of Chemistry
Co-authored papers
1
Anat Stemmer-Rachamimov
Massachusetts General Hospital
Co-authored papers
1
Sandra Goetze
ETH Zurich
Co-authored papers
1
1 - 30